𝔖 Bobbio Scriptorium

✦ LIBER ✦

IV Busulfan-Based Reduced Intensity Regimen (RIC) Before Allogeneic Stem Cell Transplantation Is Well Tolerate And Effective In Patients With Hematological Diseases

✍ Scribed by L. Castagna; S. Fürst; J. El-Cheikh; C. Faucher; N. Vey; R. Bouabdallah; A.-M. Stoppa; M. Mohty; C. Chabannon; B. Esterni; D. Blaise

Book ID: 116281616
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 50 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.12.417

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation Of Busulfan's Dose-Intensity

Evaluation Of Busulfan's Dose-Intensity In Patients Undergoing Allogeneic Stem Cell Transplantation (ASCT) With Two Different Fludarabine/Busulfan/ATG (FBA)-Based Reduced Intensity Conditioning (RIC) Regimens

✍ M. Hamadani; M. Craig; J. Abraham; W. Tse; A. Cumpston; C.J. Stotler; S.C. Remic 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT

✍ A. Shimoni; N. Shem-Tov; A. Rand; Y. Volchek; R. Yerushalmi; I. Hardan; A. Nagle 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Comparison between two fludarabine-based

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Rand, A; Herscovici, C; Yerushalmi, R; Nagle 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB

CD34+ Cell Dose and Full Donor Chimerism

CD34+ Cell Dose and Full Donor Chimerism at Day +100 Is Associated with Survival in Patients Who Received Reduced-Intensity Conditioning (RIC) With Fludarabine/Melphalan Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies

✍ S.G. Holtan; W.J. Hogan; M.A. Elliott; D.A. Gastineau; T.G. Call; S.A. Ansell; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

229: Twice-Daily Intravenous (IV) Busulf

229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults

✍ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Reduced Intensity Conditioning (RIC) All

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (AlloSCT) In Children and Adolescent Recipients is Associated With Very Low Regimen Related and Non-Relapse Mortality (NRM): However, Chemonaive Patients Following Umbilical Cord Blood Transplant (UCBT) have a Higher Incidence of Primary Graft Failure (PGF)

✍ P. Satwani; B. Tallamy; Z. Jin; V. Kohl; J. Garvin; M. Bhatia; D. George; B. Bra 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 90 KB